Sail from Sydney to London on an Unforgettable Adventure Calling on 80 Ports in 34 Countries MIAMI , Aug. 6, 2025 /PRNewswire/ -- Oceania Cruises ® , the world's leading culinary- and destination-focused luxury cruise line, is redefining luxury global exploration with its new Kangaroo Route sailing, an extraordinary 129-day Around the World voyage visiting more than 80 ports across 34 countries and four continents, aboard the critically acclaimed Oceania Vista. Featuring overnight stays in Cairns, Shanghai, Tokyo, Singapore, Mumbai, Luxor and Bordeaux, bookings for this epic journey – a new segment of the 2027 Around the World cruise – …

image for news Oceania Cruises® Unveils a Global Journey of Discovery: The Kangaroo Route, aboard Oceania Vista®

CFC To Host Conference Call on Fiscal Year 2025 Financial Results — Neutral

NRUC   GlobeNewsWire — August 06, 2025

DULLES, Va., Aug. 06, 2025 (GLOBE NEWSWIRE) -- The National Rural Utilities Cooperative Finance Corporation (CFC) will hold an investor conference call and webcast on Friday, August 8, at 10 a.m. Eastern Time. CFC CEO Andrew Don will provide a business update and CFC Senior Vice President and CFO Ling Wang will review CFC's fiscal year 2025 financial results.

image for news CFC To Host Conference Call on Fiscal Year 2025 Financial Results

Snap shares tumbled in premarket trading on Wednesday after Citizens downgraded the social media company following a second-quarter revenue miss. Analyst Andrew Boone cut his rating on the stock to market perform from market outperform and removed his previous $12 per share price target.

image for news Snap shares plunge 18% in premarket open after Citizens downgrade over Q2 miss

Novo Nordisk Slumps As It Cautions 'Unsafe And Unlawful' Knockoffs Will Pressure Wegovy — Negative

NVO   Investors Business Daily — August 06, 2025

Novo Nordisk stock slumped Wednesday after saying it expects compounded versions to undercut sales of its obesity drug, Wegovy.

image for news Novo Nordisk Slumps As It Cautions 'Unsafe And Unlawful' Knockoffs Will Pressure Wegovy

Globalstar to Participate in Upcoming Investor Conferences — Neutral

GSAT   Business Wire — August 06, 2025

COVINGTON, La.--(BUSINESS WIRE)--Globalstar, Inc. (Nasdaq: GSAT) (“Globalstar” or the “Company”), a next-generation telecommunications infrastructure and technology provider, today announced that members of the Company will be participating at the following upcoming investor conferences: Morgan Stanley Media & Communications Corporate Access Day Date: Tuesday, August 12, 2025 Location: New York, NY Format: One-on-one or Group Meetings TD Securities Technology Growth Capital Summit Date: Thu.

image for news Globalstar to Participate in Upcoming Investor Conferences

Bentley Systems, Incorporated (BSY) Beats Q2 Earnings and Revenue Estimates — Positive

BSY   Zacks Investment Research — August 06, 2025

Bentley Systems, Incorporated (BSY) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.31 per share a year ago.

image for news Bentley Systems, Incorporated (BSY) Beats Q2 Earnings and Revenue Estimates

Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates — Positive

CRL   Zacks Investment Research — August 06, 2025

Charles River Laboratories (CRL) came out with quarterly earnings of $3.12 per share, beating the Zacks Consensus Estimate of $2.5 per share. This compares to earnings of $2.8 per share a year ago.

image for news Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates

Arvinas, Inc. (ARVN) Reports Q2 Loss, Misses Revenue Estimates — Negative

ARVN   Zacks Investment Research — August 06, 2025

Arvinas, Inc. (ARVN) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $0.87. This compares to a loss of $0.49 per share a year ago.

image for news Arvinas, Inc. (ARVN) Reports Q2 Loss, Misses Revenue Estimates

Diebold Nixdorf, Incorporated (DBD) Misses Q2 Earnings Estimates — Negative

DBD   Zacks Investment Research — August 06, 2025

Diebold Nixdorf, Incorporated (DBD) came out with quarterly earnings of $0.6 per share, missing the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $1.16 per share a year ago.

image for news Diebold Nixdorf, Incorporated (DBD) Misses Q2 Earnings Estimates

Extreme Networks (EXTR) Q4 Earnings and Revenues Beat Estimates — Positive

EXTR   Zacks Investment Research — August 06, 2025

Extreme Networks (EXTR) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to a loss of $0.08 per share a year ago.

image for news Extreme Networks (EXTR) Q4 Earnings and Revenues Beat Estimates

Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates — Negative

GERN   Zacks Investment Research — August 06, 2025

Geron (GERN) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.1 per share a year ago.

image for news Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates

Rivian Is Doomed — Negative

RIVN   24/7 Wall Street — August 06, 2025

Small electric vehicle (EV) companies aren't going to make it, especially as demand for EVs in the U.S.

image for news Rivian Is Doomed

Ceragon Networks (CRNT) Q2 Earnings Match Estimates — Positive

CRNT   Zacks Investment Research — August 06, 2025

Ceragon Networks (CRNT) came out with quarterly earnings of $0.03 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.11 per share a year ago.

image for news Ceragon Networks (CRNT) Q2 Earnings Match Estimates

Valvoline (VVV) Surpasses Q3 Earnings and Revenue Estimates — Positive

VVV   Zacks Investment Research — August 06, 2025

Valvoline (VVV) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.45 per share a year ago.

image for news Valvoline (VVV) Surpasses Q3 Earnings and Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates — Negative

TRDA   Zacks Investment Research — August 06, 2025

Entrada Therapeutics, Inc. (TRDA) came out with a quarterly loss of $1.04 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to earnings of $1.55 per share a year ago.

image for news Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates

Lucid Is Doomed — Negative

LCID   24/7 Wall Street — August 06, 2025

Lucid Group Inc. (NASDAQ: LCID) stock collapsed 7% after hours when it announced terrible earnings.

image for news Lucid Is Doomed

Beijing/Hong Kong, Aug. 06, 2025 (GLOBE NEWSWIRE) -- KUKE Music (NYSE: KUKE), a world-leading classical music content service provider, today announced a strategic collaboration with Naxos Music Group, the world's largest independent classical music group. With a catalog of over 3 million audio tracks spanning more than 100 countries and regions, Naxos is the undisputed global leader in classical music. Under this partnership, Naxos will leverage its unparalleled content resources and service infrastructure to support KUKE Music's exploration of artificial intelligence (AI) innovations, blockchain and RWA (Real World Assets) in classical music. The collaboration centers on building a blockchain- and …

image for news KUKE Music Partners with Global Classical Music Giant Naxos to Launch "Music LEGO Engine," Reshaping Classical Music Future with AI, Blockchain and RWA

Purpose-built analytics tools turn real-time Roblox gameplay data into actionable insights— unlocking new value for marketers, developers, investors, and analysts as the ecosystem scales

image for news Super League Taps Surging Demand for Roblox Trend Intelligence with Early Adoption of ‘Rotrends Pro' Subscription Service

ATLANTA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development‐stage biotechnology company developing new medicines to treat pain and fatigue-related disorders, announced today that it will report second quarter 2025 financial results on Wednesday, August 13, 2025 before the open of the financial markets.

image for news Dogwood Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

Jon Tower, Citi restaurant analyst, joins 'Squawk Box' to break down McDonald's quarterly earnings results.

image for news Citi's Jon Tower on McDonald's Q2 results: The product momentum continues to build from here